Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer
about
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesTargeting AMPK for cancer prevention and treatment.AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts.Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancerIntact LKB1 activity is required for survival of dormant ovarian cancer spheroidsThe pentacyclic triterpenoid, plectranthoic acid, a novel activator of AMPK induces apoptotic death in prostate cancer cells.Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.Down-regulation of adenosine monophosphate-activated protein kinase activity: A driver of cancer.Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime.Correction: Reduced expression of AMPK-ß1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer.Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
P2860
Q28081491-B1D01A13-3942-4721-B80A-E5F7200F8ECDQ35781311-8D7E065E-A8DD-434A-92B2-84DBB4D960DAQ35828452-C6C5092B-93C8-4D97-BFA7-EFD5A0C56E46Q36057092-B3AE01E8-AEB2-4E46-883E-FAD33B472C90Q36355979-2D343F6B-1F72-4BEE-951C-4917B0A626D8Q36782275-3DF32798-79B7-4645-A8A7-2E600261C780Q36949580-C502F412-5B5A-4325-BFC8-BB23BA1A2953Q38807302-65EEC4A4-9FFB-4057-8C93-5810F950D1F0Q39222558-10C9CA03-8D37-453F-8DCF-A6F35850660EQ40037417-70E373DC-A499-453B-8F68-53FADE2F6C66Q45939013-1705B358-3A57-4D3D-A3E9-F1BE55CC9071Q46799064-2414B459-5AF8-4E22-A932-EA1D67CB17A9
P2860
Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Reduced expression of AMPK-β1 ...... ity of advanced ovarian cancer
@ast
Reduced expression of AMPK-β1 ...... ity of advanced ovarian cancer
@en
type
label
Reduced expression of AMPK-β1 ...... ity of advanced ovarian cancer
@ast
Reduced expression of AMPK-β1 ...... ity of advanced ovarian cancer
@en
prefLabel
Reduced expression of AMPK-β1 ...... ity of advanced ovarian cancer
@ast
Reduced expression of AMPK-β1 ...... ity of advanced ovarian cancer
@en
P2093
P2860
P356
P1433
P1476
Reduced expression of AMPK-β1 ...... ity of advanced ovarian cancer
@en
P2093
Kwok-Ming Yao
Pui Man Chiu
Vincent W S Liu
P2860
P2888
P356
10.1186/1476-4598-13-49
P577
2014-03-06T00:00:00Z
P5875
P6179
1041357942